Medulloblastoma is a heterogeneous disease comprising four molecular subgroups - wingless (WNT), sonic hedge hog (SHH), group 3, and group 4, with distinct developmental origins, unique transcriptional profiles, diverse phenotypes, and varying clinical outcomes. Magnetic resonance imaging (MRI) is the preferred first-line imaging modality in the diagnosis and staging of suspected brain tumors including medulloblastoma. It is being increasingly recognized that imaging features reflect underlying disease biology that can serve as independent predictive and prognostic biomarkers. Radiogenomics is an emerging field of research that aims to define relationships between non-invasive imaging features (radio-phenotypes) and genomic data/molecular m...
BACKGROUND AND PURPOSE: The occurrence of medulloblastomas in adults is rare; nevertheless, these tu...
Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in...
Background: Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk strati...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
Background: Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk strati...
Medulloblastoma is the most prevalent malignant brain tumor in children, accounting for roughly 15% ...
BACKGROUND AND PURPOSE: Recently identified molecular subgroups of medulloblastoma have shown potent...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
BACKGROUND AND PURPOSE: Recently identified molecular subgroups of medulloblastoma have shown potent...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
Medulloblastoma (MB) is the most common malignant pediatric posterior fossa tumor. Recent genetic, e...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
BACKGROUND AND PURPOSE: The occurrence of medulloblastomas in adults is rare; nevertheless, these tu...
Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in...
Background: Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk strati...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
Background: Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk strati...
Medulloblastoma is the most prevalent malignant brain tumor in children, accounting for roughly 15% ...
BACKGROUND AND PURPOSE: Recently identified molecular subgroups of medulloblastoma have shown potent...
Background: Children with medulloblastoma have a 72% chance of surviving more than 5 years under cur...
BACKGROUND AND PURPOSE: Recently identified molecular subgroups of medulloblastoma have shown potent...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
Medulloblastoma (MB) is the most common malignant pediatric posterior fossa tumor. Recent genetic, e...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
The 2016 WHO classification of central nervous system tumors has included four molecular subgroups u...
BACKGROUND AND PURPOSE: The occurrence of medulloblastomas in adults is rare; nevertheless, these tu...
Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in...
Background: Radiogenomics of pediatric medulloblastoma (MB) offers an opportunity for MB risk strati...